Approach to reduce the non-specific binding in microdialysis

Journal of Neuroscience Methods

Volumn 209, Issue 2, 2012, Pages 379-387

  Nirogi, Ramakrishna ^a   Kandikere, Vishwottam ^a   Bhyrapuneni, Gopinadh ^a   Benade, Vijay ^a   Saralaya, Ramanatha ^a   Irappanavar, Shantaveer ^a   Muddana, Nageswararao ^a   Ajjala, Devender Reddy ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

Adsorption; Brain pharmacokinetics; Microdialysis; Non specific binding; Probe extraction efficiency

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; DONEPEZIL; ESCITALOPRAM; OLANZAPINE; QUETIAPINE; RACLOPRIDE;

ADSORPTION KINETICS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG ADSORPTION; DRUG BINDING; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; IONIZATION; LIPOPHILICITY; MALE; MEMBRANE BINDING; MICRODIALYSIS; NONHUMAN; PH; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BRAIN; CARBAMAZEPINE; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; PHARMACOKINETICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864046741     PISSN: 01650270     EISSN: 1872678X     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2012.06.010     Document Type: Article

References (23)

1. Bundgaard C., Jorgensen M., Mork A. An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents. J Pharmacol Toxicol Methods 2007, 55:214-223.
2. Bundgaard C., Sveigaard C., Brennum L.T., Stensbol T.B. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations. Xenobiotica 2012, 42:256-265.
3. Carneheim C., Stahle L. Microdialysis of lipophilic compounds: a methodological study. Pharmacol Toxicol 1991, 69:378-380.
4. Davies M.I., Cooper J.D., Desmond S.S., Lunte C.E., Lunte S.M. Analytical considerations for microdialysis sampling. Adv Drug Deliv Rev 2000, 45:169-188.
5. de Lange E.C., Danhof M. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting. Clin Pharmacokinet 2002, 41:691-703.
6. de Lange E.C., Ravenstijn P.G., Groenendaal D., van Steeg T.I. Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism based pharmacokinetic-pharmacodynamic modeling. AAPS J 2005, 7:E532-E543.
7. Erdo F., Gordon J., Wu J.T., Sziraki I. Verification of brain penetration of the unbound fraction of a novel HER2/EGFR dual kinase inhibitor (TAK-285) by microdialysis in rats. Brain Res Bull 2012, 87:413-419.
8. Khramov A.N., Stenken J.A. Enhanced microdialysis recovery of some tricyclic antidepressants and structurally related drugs by cyclodextrin-mediated transport. Analyst 1999, 124:1027-1033.
9. Khramov A.N., Stenken J.A. Enhanced microdialysis extraction efficiency of ibuprofen in vitro by facilitated transport with β-cyclodextrin. Anal Chem 1999, 71:1257-1264.
10. Letrent S.P., Pollack G.M., Brouwer K.R., Brouwer K.L.R. Effects of a potent and specific p-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat. Drug Metab Dispos 1999, 27:827-834.
11. Lindberger M., Tomson T., Lars S. Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device. Pharmacol Toxicol 2002, 91:158-165.
12. Liu X., Chen C., Smith B.J. Progress in brain penetration evaluation in drug discovery and development. J Pharmacol Exp Ther 2008, 325:349-356.
13. Loos W.J., Zamboni W.C., Engels F.K., de Bruijn P., Lam M.H., de Wit R., et al. Pitfalls of the application of microdialysis in clinical oncology: controversial finding with docetaxel. J Pharm Biomed Anal 2007, 45:288-294.
14. Nirogi R., Bhyrapuneni G., Kandikere V., Benade V., Muddana N., Saralaya R., et al. Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats. Eur J Drug Metab Pharmacokinet 2012, 10.1007/s13318-012-0081-1.
15. Paxinos G., Watson C. Rat brain in stereotaxic coordinates 2004, New York, Academic Press.
16. Pitt W.G., Grasel T.G., Cooper S.L. Albumin adsorption on alkyl chain derivatized polyurethanes. II. The effect of alkyl chain length. Biomaterials 1988, 9:36-46.
17. Schwartz M., Kline W., Matuszewski B. Determination of a cyclic hexapeptide (L-743 872), a novel pneumocandin antifungal agent in human plasma and urine by high-performance liquid chromatography with fluorescence detection. Anal Chim Acta 1997, 352:299-307.
18. Shen D.D., Artu A.A., Adkinson K.K. Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics. Adv Drug Deliv Rev 2004, 56:1825-1857.
19. Silvester S., Zang F. Overcoming non-specific adsorption issues for AZD9164 in human urine samples: consideration of bioanalytical and metabolite identification procedures. J Chromatogr B Analyt Technol Biomed Life Sci 2012, 893-894:134-143.
20. Torto N., Bang J., Richardson S., Nilsson G.S., Gorton L., Laurell T., et al. Optimal membrane choice for microdialysis sampling of oligosaccharides. J Chromatogr A 1998, 806:265-278.
21. Traunmuller F., Steiner I., Zeitlinger M., Joukhadar C. Development of a high-performance liquid chromatography method for the determination of capsofungin with amperometric detection and its application to in vitro microdialysis experiments. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 843:142-146.
22. Trickler W.J., Miller D.W. Use of osmotic agents in microdialysis studies to improve the recovery of macromolecules. J Pharm Sci 2003, 92:1419-1427.
23. Woo K.L., Lunte C.E. The development of multiple probe microdialysis sampling in the stomach. J Pharm Biomed Anal 2008, 48:20-26.